Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand
- 1 January 2007
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 25 (5) , 413-428
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The Safety of Discontinuation of Maintenance Therapy for Cytomegalovirus (CMV) Retinitis and Incidence of Immune Recovery Uveitis Following Potent Antiretroviral TherapyHIV Research & Clinical Practice, 2005
- Seven Years of HAART Impact on Ophthalmic Management of HIV-Infected PatientsOcular Immunology and Inflammation, 2005
- Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implantBrazilian Journal of Medical and Biological Research, 2000
- DiscussionAmerican Journal of Ophthalmology, 1999
- Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDSPharmacoEconomics, 1999
- Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ countsOphthalmology, 1998
- Pharmacoeconomic Analysis of 3 Treatment Strategies for Cytomegalovirus Retinitis in Patients with AIDSPharmacoEconomics, 1998
- Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir ImplantNew England Journal of Medicine, 1997
- A Utility Assessment of Oral and Intravenous Ganciclovir for the Maintenance Treatment of AIDS-Related Cytomegalovirus RetinitisPharmacoEconomics, 1996
- An economic evaluation of oral compared with intravenous ganciclovir for maintenance treatment of newly diagnosed for maintenance treatment of newly diagnosed cytomegalovirus retinitis in AIDS patientsClinical Therapeutics, 1996